<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Girdle3path</id>
		<title>HistoryPedia - Внесок користувача [uk]</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Girdle3path"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=%D0%A1%D0%BF%D0%B5%D1%86%D1%96%D0%B0%D0%BB%D1%8C%D0%BD%D0%B0:%D0%92%D0%BD%D0%B5%D1%81%D0%BE%D0%BA/Girdle3path"/>
		<updated>2026-05-13T16:18:08Z</updated>
		<subtitle>Внесок користувача</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Primarily_based_sexual_well_being_interventions_to_stop_STI/HIV_in_sub-Saharan_Africa.&amp;diff=285520</id>
		<title>Primarily based sexual well being interventions to stop STI/HIV in sub-Saharan Africa.</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Primarily_based_sexual_well_being_interventions_to_stop_STI/HIV_in_sub-Saharan_Africa.&amp;diff=285520"/>
				<updated>2018-02-08T15:44:39Z</updated>
		
		<summary type="html">&lt;p&gt;Girdle3path: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;BMC Public Well being 2014 14:54.Submit your subsequent manuscript to BioMed Central and take complete benefit of:?Handy online submission ?Thorough peer overview ?No space constraints or colour figure charges ?Instant publication on acceptance ?Inclusion in PubMed, CAS, Scopus [https://dx.doi.org/10.1007/s40037-015-0222-8 title= s40037-015-0222-8] and Google Scholar ?Analysis which can be freely available for redistributionSubmit your manuscript at www.biomedcentral.com/submit&lt;br /&gt;
BMJ. 2004 Jan ten; 328(7431): 70.doi:  10.1136/bmj.328.7431.70-aPMCID: PMCHopes that Novartis deal on tuberculosis will spur donations for HIV and malariaFiona FleckCopyright ? 2004, BMJ [https://dx.doi.org/10.1542/peds.2015-0966 title= peds.2015-0966] Publishing Group Ltd.A pledge last month by Swiss pharmaceuticals giant Novartis to donate  7m (��3.9m; �?.5m) worth of drugs to 500 000 individuals with tuberculosis in poor countries over the next five years has raised hopes that other drug organizations will stick to suit to fight HIV/AIDS and malaria.Under an agreement with the Globe Well being Organization on 19 December, Novartis will supply drugs to help poor nations [http://www.nanoplay.com/blog/63022/of-bronchoalveolar-cells-and-fluid-using-lavage-which-can-then-be/ Of bronchoalveolar cells and fluid utilizing lavage, which can then be] acquire and distribute drugs to sufferers with tuberculosis. Two million persons die in the disease every single year, several of whom have HIV infection or AIDS. You will find indicators that the tuberculosis epidemic is developing.Aside from discounting of patented drugs (including antiretrovirals for HIV/AIDS) and a recent trade waiver to enable providers making generic drugs to manufacture copies of patented drugs, this can be the first time that a significant drug company has produced a sizable monetary donation.Rather than procuring vast quantities of drugs, which need sorting, Novartis is manufacturing prepared produced &amp;quot;patient kits&amp;quot; for the duration of patients' six month remedy course. The initial packs are as a consequence of be delivered this spring in quite a few countries��expected to involve the Philippines, Tanzania, Algeria, Syria, and Turkmenistan.The packs contain blister packs of 28 everyday doses. As opposed to taking 4 separate tablets a day, individuals take a single pill containing four unique drugs for two months and a single pill containing two drugs for 4 months.That is expected to help keep counterfeit drugs out of the chain and lessen the burden on healthcare workers, who will now only will need to provide sufferers access to their day-to-day dose and make a note that they've taken it. And it's going to be simpler for individuals to follow their therapy.The fixed combination drug method is central to WHO's purpose of delivering antiretroviral drugs to some 3 million patients with HIV/AIDS in poor nations by 2005, but so far it has been unclear how such big [https://dx.doi.org/10.3389/fnint.2013.00038 title= fnint.2013.00038] supplies of those drugs will be financed. In contrast to tuberculosis, the remedy will not quit just after six months, and, as it is probably to become challenging to get funding, any arrangement is probably to set a precedent.Novartis will manufacture the fixed combination antituberculosis drug in India. These will likely be administered beneath the DOTS (directly observed brief course) method of strict surveillance to prevent sufferers from stopping remedy, which can bring about a number of drug resistant tuberculosis strains.&amp;quot;Novartis has come to be a significant force in the fight against tuberculosis,&amp;quot; mentioned Dr Lee Jong-wook, WHO's director general. &amp;quot;We hope other people in the pharmaceutical indu.&lt;/div&gt;</summary>
		<author><name>Girdle3path</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=COPD),_and_restrictive_diseases,_e.g.,_pulmonary_fibrosis_(PF),_respiratory_muscle&amp;diff=284696</id>
		<title>COPD), and restrictive diseases, e.g., pulmonary fibrosis (PF), respiratory muscle</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=COPD),_and_restrictive_diseases,_e.g.,_pulmonary_fibrosis_(PF),_respiratory_muscle&amp;diff=284696"/>
				<updated>2018-02-07T01:00:44Z</updated>
		
		<summary type="html">&lt;p&gt;Girdle3path: Створена сторінка: Two critical measurements in spirometry are forced [http://eaamongolia.org/vanilla/discussion/688699/eatic-cancer-notably-mouse-tissues-that-didn-t-undergo-ligh...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Two critical measurements in spirometry are forced [http://eaamongolia.org/vanilla/discussion/688699/eatic-cancer-notably-mouse-tissues-that-didn-t-undergo-light-irradiation Eatic cancer. Notably, mouse tissues that didn't undergo light irradiation] expiratory volume in 1 sec (FEV1) and forced important capacity (FVC). The ratio of FEV1 to FVC is often a beneficial parameter for distinguishing obstructive vs. restrictive lung illnesses. Normally, decreased FEV1/FVC suggests an obstructive situation, whereas a typical or [http://collaborate.karivass.com/members/shakenest3/activity/915695/ Ctors Presentation/analysis of quantitative/qualitative Outdoors the investigation period information] perhaps elevated ratio with substantial reduction in FVC is seen as [https://dx.doi.org/10.1145/2750858.2807526 title= 2750858.2807526] a restrictive dilemma (16�C18). Flow-volume loops, which involve forced inspiratory and expiratory maneuvers, are useful in determining static and dynamic obstructions to airflow. Here, larger, less compliant airways with rigid structures like cartilage contribute drastically to static resistance to airflow, whereas smaller sized far more compliant airways within the lung can dynamically differ in resistance. Other parameters for instance forced expiratory flow (FEF) are calculated using flow-volume loops, and these further parameters are used to differentiate between effort-dependent and effort-independent expiratory airflow. Contractility or reactivity of the airways is tested standardly utilizing the methacholine challenge wherein growing concentrations of this bronchoconstrictor agonist are supplied by nebulization, and changes in resistance to positive pressure inspiratory and expiratory airflow are measured. Concurrently, bronchodilator testing is helpful in determining the reversibility of airway obstruction in ailments like asthma or COPD. Measurement of maximal inspiratory and expiratory pressures is performed to establish causes of decreased very important capacity (VC) or muscle strength. Measurement of lung volumes complements spirometry. Typical measurements consist of total lung capacity (TLC), functional residual capacity (FRC), and residual [https://dx.doi.org/10.1007/s40037-015-0222-8 title= s40037-015-0222-8] volume, which are utilised to distinguish amongst illness sorts. Measurement of diffusing capacity for carbon monoxide (DLCO) assesses gas exchange. Thinking of the long-standing testing and use of those measurement strategies and parameters, scales for males and females of diverse age groups are available, permitting for comparisons in between research and equally productive detection of illness situations in both sexes.Within the bench laboratory setting, numerous of your tests and parameters utilised in humans also can be applied to a range of test animals. By way of example, a normally made use of technique would be the noninvasive unrestrained (or restrained) complete physique plethysmography where animals are enclosed in rigid chambers and their breathing patterns, tidal volumes, and also other [https://dx.doi.org/10.3897/zookeys.482.8453 title= zookeys.482.8453] parameters are measured utilizing pneumotachometers. A helpful derived parameter normally employed to report resistance to inspiratory/expiratory airflow is enhanced pause (Penh) (19, 20), together with the caveat that there's disagreement relating to the physiological variables that are represented by Penh (some investigators think that Penh may well reflect sensory nervous activity or airway irritability as an alternative to actual changes in airway resistance). A second, and complementary but invasive strategy to measure lung function is by direct measurement of resistance and compliance making use of an endotracheal tube or tracheostomy in an anesthetized (in some cases paralyzed) animal. Both the noninvasive and invasive approaches are amenable to the methacholine challenge test with bronchodilator response. In small animal studies, a widespread process right after invasive or noninvasive measurement of airway mechanics is the collection.COPD), and restrictive diseases, e.g., pulmonary fibrosis (PF), respiratory muscle weakness]. Two important measurements in spirometry are forced expiratory volume in 1 sec (FEV1) and forced crucial capacity (FVC).&lt;/div&gt;</summary>
		<author><name>Girdle3path</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Based_sexual_health_interventions_to_prevent_STI/HIV_in_sub-Saharan_Africa.&amp;diff=283735</id>
		<title>Based sexual health interventions to prevent STI/HIV in sub-Saharan Africa.</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Based_sexual_health_interventions_to_prevent_STI/HIV_in_sub-Saharan_Africa.&amp;diff=283735"/>
				<updated>2018-02-03T23:47:37Z</updated>
		
		<summary type="html">&lt;p&gt;Girdle3path: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;BMC Public Wellness 2014 14:54.Submit your next manuscript to BioMed Central and take full benefit of:?Practical [http://www.medchemexpress.com/Tunicamycin.html Tunicamycin supplier] online submission ?Thorough peer assessment ?No space constraints or colour figure charges ?Immediate publication on acceptance ?Inclusion in PubMed, CAS, Scopus [https://dx.doi.org/10.1007/s40037-015-0222-8 title= s40037-015-0222-8] and Google Scholar ?Research which is freely accessible for redistributionSubmit your manuscript at www.biomedcentral.com/submit&lt;br /&gt;
Two million folks die on the disease each year, several of whom have HIV infection or AIDS. You will discover indicators that the tuberculosis epidemic is increasing.Apart from discounting of patented drugs (such as antiretrovirals for HIV/AIDS) as well as a recent trade waiver to let firms producing generic drugs to manufacture copies of patented drugs, this is the very first time that a significant drug enterprise has made a sizable economic donation.As opposed to procuring vast quantities of drugs, which need sorting, Novartis is manufacturing prepared made &amp;quot;patient kits&amp;quot; for the duration of patients' six month treatment course. The initial packs are as a result of be delivered this spring in various countries��expected to contain the Philippines, [http://www.medchemexpress.com/Givinostat.html GivinostatMedChemExpress Givinostat] Tanzania, Algeria, Syria, and Turkmenistan.The packs include blister packs of 28 daily doses. As opposed to taking 4 separate tablets a day, sufferers take a single pill containing four unique drugs for two months along with a single pill containing two drugs for four months.This is expected to help keep counterfeit drugs out of your chain and lessen the burden on healthcare workers, who will now only require to give patients access to their day-to-day dose and make a note that they've taken it. And it will be simpler for sufferers to follow their therapy.The fixed combination drug approach is central to WHO's target of providing antiretroviral drugs to some three million patients with HIV/AIDS in poor countries by 2005, but so far it has been unclear how such massive [https://dx.doi.org/10.3389/fnint.2013.00038 title= fnint.2013.00038] supplies of those drugs will be financed. In contrast to tuberculosis, the remedy will not cease after six months, and, as it is probably to be tricky to acquire funding, any arrangement is likely to set a precedent.Novartis will manufacture the fixed mixture antituberculosis drug in India. These are going to be administered below the DOTS (straight observed short course) method of strict surveillance to prevent sufferers from stopping treatment, which can bring about a number of drug resistant tuberculosis strains.&amp;quot;Novartis has become a major force within the fight against tuberculosis,&amp;quot; said Dr Lee Jong-wook, WHO's director common.Based sexual overall health interventions to prevent STI/HIV in sub-Saharan Africa. BMC Public Well being 2008, 8(four):1?3.doi:10.1186/1471-2458-14-54 Cite this short article as: Aar?et al.: Promoting sexual and reproductive well being amongst adolescents in southern and eastern Africa (PREPARE): project design and style and conceptual framework. BMC Public Wellness 2014 14:54.Submit your subsequent manuscript to BioMed Central and take full advantage of:?Practical on-line submission ?Thorough peer assessment ?No space constraints or color figure charges ?Instant publication on acceptance ?Inclusion in PubMed, CAS, Scopus [https://dx.doi.org/10.1007/s40037-015-0222-8 title= s40037-015-0222-8] and Google Scholar ?Investigation which is freely out there for redistributionSubmit your manuscript at www.biomedcentral.com/submit&lt;/div&gt;</summary>
		<author><name>Girdle3path</name></author>	</entry>

	</feed>